AG
BCAB

Algert Global’s BIOATLA INC BCAB Stock Holding History

Algert Global’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-420
Closed -$35.7K – 1132
2023
Q3 		$35.7K Hold
420
– – ﹤0.01% 1078
2023
Q2 		$63K Buy
420
+109
+35% +$18.7K ﹤0.01% 1051
2023
Q1 		$41.7K Buy
+311
New +$56K ﹤0.01% 1107

Other funds holding BCAB

SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Algert Global's BCAB Position: Q4 2023 in Review

Algert Global sold out of BIOATLA INC (BCAB) in Q4 2023, closing a stake of 420 shares — an estimated $35.7K sold.

Algert Global first reported a position in BCAB in Q1 2023 and held it in 3 quarters. The position peaked at $63K in Q2 2023. 79 funds tracked by Wall St. Rank hold BCAB as of Q4 2023.

  • Algert Global reported no remaining BIOATLA INC position as of Q4 2023 after selling out during the quarter.
  • Algert Global sold 420 BIOATLA INC shares in Q4 2023, an estimated $35.7K.
  • Algert Global first reported a position in BIOATLA INC in Q1 2023 and held it in 3 quarters.
  • Algert Global's BIOATLA INC position peaked at $63K in Q2 2023.
  • 79 funds tracked by Wall St. Rank held BIOATLA INC as of Q4 2023.

Based on Algert Global's 13F filing for Q4 2023, filed 14 Feb 2024.